1. A different perspective on sofosbuvir‐ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital‐c network study. Issue 1 (30th August 2017) Authors: Barone, M.; Iannone, A.; Shahini, E.; Ippolito, A. M.; Brancaccio, G.; Morisco, F.; Milella, M.; Messina, V.; Smedile, A.; Conti, F.; Gatti, P.; Santantonio, T.; Tundo, P.; Lauletta, G.; Napoli, N.; Masetti, C.; Termite, A. P.; Francavilla, R.; Di Leo, A.; Pesce, F. Journal: Journal of viral hepatitis Issue: Volume 25:Issue 1(2018) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro. (15th February 2015) Authors: Colagrossi, L.; Salpini, R.; Surdo, M.; Battisti, A.; Pollicita, M.; Bertoli, A.; Di Santo, F.; Becker, C.; Mastroianni, C.; Marignani, M.; Maylin, S.; Delaugerre, C.; Morisco, F.; Coppola, N.; Marrone, A.; Sarmati, L.; Andreoni, M.; Angelico, M.; Verheyen, J.; Perno, C.F. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.82 THE ROLE OF THE PNPLA3, TM6SF2 AND MBOAT7 GENETIC VARIANTS IN THE RESPONSE TO NUTRACEUTICAL THERAPY FOR NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS. (September 2021) Authors: Dallio, M.; Romeo, M.; Masarone, M.; Persico, M.; Morisco, F.; Loguercio, C.; Federico, A. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AF.90 RISK FACTORS FOR LIVER DECOMPENSATION AND HCC IN HCV-CIRRHOTIC PATIENTS AFTER DAAS: A MULTICENTER PROSPECTIVE STUDY. (September 2021) Authors: Guarino, M.; Pontillo, G.; Federico, A.; Marignani, M.; Cannavò, M.; Pignata, L.; Cossiga, V.; Capasso, M.; Dallio, M.; Begini, P.; Benigno, R.; Lombardo, F.; Stroffolini, T.; Morisco, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AF.93 COVID-19 IN LIVER TRANSPLANT RECIPIENTS: AN ITALIAN CASE-CONTROL DOUBLE-CENTER STUDY. (September 2021) Authors: Guarino, M.; Cossiga, V.; Loperto, I.; Esposito, I.; Ortolani, R.; Fiorentino, A.; Pontillo, G.; De Coppi, L.; Pignata, L.; Capasso, M.; Cozza, V.; Di Costanzo, G.G.; Picciotto, F.P.; Morisco, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C. (February 2020) Authors: Barbaliscia, S.; Di Maio, V.C.; Fabeni, L.; Teti, E.; Paolucci, S.; Minichini, C.; Aragri, M.; Rosa, K. Yu La; Carioti, L.; Pasquazzi, C.; Milana, M.; Foroghi, L.; Pollicino, T.; Licata, A.; Pieri, A.; Palitti, V. Pace; Bruzzone, B.; Micheli, V.; Bertoli, A.; Baiocchi, L. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Berberis aristata, Elaeis guineensis and Coffea canephora extracts modulates the microRNA-122 expression and improves hepatic steatosis in mice fed high fat diet. Issue 1 (February 2018) Authors: Lembo, V.; Mirra, P.; Mazzone, G.; Rossi, A.; D'Argenio, G.; Cossiga, V.; Nigro, C.; Miele, C.; Beguinot, F.; Caporaso, N.; Morisco, F. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy. Issue 1 (February 2018) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Lenci, I.; Aragri, M.; Polilli, E.; Fiorentino, G.; Pace Palitti, V.; Bruzzone, B.; Paolucci, S.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Niero, F.; Micheli, V.; Nicolini, L.A.; Marenco, S.; Bertoli, A.; Maida, I.; Francioso, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study. (15th February 2015) Authors: Piscaglia, F.; Baroni, G. Svegliati; Barchetti, A.; Pecorelli, A.; Marinelli, S.; Tiribelli, C.; Bellentani, S.; Bolondi, L.; Zoli, M.; Malagotti, D.; Brandi, G.; Bugianesi, E.; Vanni, E.; Mezzabotta, L.; Cabibbo, G.; Petta, S.; Fracanzani, A.; Fargion, S.; Marra, F.; Fani, B. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗